Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy
Status:
Completed
Trial end date:
2017-07-08
Target enrollment:
Participant gender:
Summary
To compare the efficacy of a Brinzolamide/Brimonidine fixed combination (FC) with Brimonidine
0.2% in preventing intraocular pressure (IOP) elevations after neodymium:
yttrium-aluminum-garnet (Nd:YAG) laser posterior capsulotomy.